StockWatch
·
Pharmaceuticals
Quarterly Result29 May 2026, 06:33 pm

Lasa Supergenerics Q4 FY26 Loss ₹397.68 Lakhs

AI Summary

Lasa Supergenerics Ltd's board approved the unaudited financial results for the quarter ended March 31, 2026. The company reported a loss before tax of ₹397.68 lakhs for the quarter. Revenue from operations stood at ₹(13.15) lakhs. The results were reviewed by the audit committee and approved by the board on May 29, 2026. A fire incident at the company's factory in May 2025 resulted in significant losses, impacting production activities.

Key Highlights

  • Lasa Supergenerics reports a loss before tax of ₹397.68 lakhs for Q4 FY26.
  • Revenue from operations for Q4 FY26 is ₹(13.15) lakhs.
  • The board approved the unaudited financial results on May 29, 2026.
  • A fire incident in May 2025 continues to impact the company's operations.
  • Exceptional items include a write-off of ₹46.27 lakhs related to Capital Work-in-Progress.